Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elastic NV (ESTC) vs Immunovant Inc. Common Stock (IMVT) Price & Performance

Elastic NVTrade
Immunovant Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Elastic NV vs Immunovant Inc. Common Stock — how do they compare? Elastic NV trades at $97.35 (market cap $10.00B), while Immunovant Inc. Common Stock trades at $30.36 (market cap $6.25B). The key difference: Elastic NV is the larger of the two by market cap, and Elastic NV is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elastic NV for 10 Days and Immunovant Inc. Common Stock for 1 Days on average.

ESTCIMVT
Market Cap
$10.00B$6.25B
Volume
1,610,3371,755,411
Sector
TechnologyHealth
52-Week High
$99.91$44.96
52-Week Low
$43.30$17.03
Typical Hold Time
10 Days1 Days
Enterprise Value
$9.14B$5.35B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Elastic NV

Elastic (ESTC) trades at $96.44, up 3.59% today, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Recent product launches in AI and observability platforms highlight innovation, while profitability metrics show improvement into 2026. The current price sits near resistance at $97, with RSI indicating potential overbought conditions short-term.

Outlook remains positive given earnings momentum and product expansion, but risks include high valuation multiples and insider selling. The consensus price target of $79.50 suggests caution, though bullish sentiment prevails with 65% buy ratings. Investors should weigh growth potential against execution risks in a competitive software market.

Immunovant Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Elastic NV

Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.

Read more on ESTC →

About Immunovant Inc. Common Stock

Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.

Read more on IMVT →